dactinomycin and etidronate

dactinomycin has been researched along with etidronate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hsu, TH1
Ryan, WG1
Ryan, WG; Schwartz, TB1

Reviews

1 review(s) available for dactinomycin and etidronate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for dactinomycin and etidronate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Current diagnosis and management of Paget's disease of bone.
    Maryland state medical journal, 1977, Volume: 26, Issue:5

    Topics: Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Deformans; Plicamycin

1977
Paget's disease of bone.
    Annual review of medicine, 1977, Volume: 28

    Topics: Adult; Bone and Bones; Calcitonin; Calcium; Collagen; Dactinomycin; Etidronic Acid; Fluorides; Glucagon; Humans; Hydroxyproline; Osteitis Deformans; Parathyroid Hormone; Phosphates; Plicamycin; Regional Blood Flow

1977
Treatment of Paget's disease of bone.
    Lancet (London, England), 1973, May-12, Volume: 1, Issue:7811

    Topics: Animals; Bone Resorption; Calcitonin; Dactinomycin; Etidronic Acid; Glucagon; Humans; Osteitis Deformans; Osteoporosis; Plicamycin; Rats

1973
Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy.
    Arthritis and rheumatism, 1980, Volume: 23, Issue:10

    Topics: Aged; Alkaline Phosphatase; Antibiotics, Antineoplastic; Binding, Competitive; Dactinomycin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Kidney; Liver; Male; Middle Aged; Osteitis Deformans; Platelet Count; Plicamycin; RNA

1980